Credit photo: GSMA MWC

The Germans Trias i Pujol Research Institute (IGTP) actively participated in Mobile World Congress 2025 (MWC25) and the 4 Years From Now (4YFN) platform, contributing its expertise in artificial intelligence, clinical data, genomics, and digital health innovation. Researchers and projects from the institute played a key role in several sessions and discussions, as well as in showcasing emerging biomedical technologies.

Participation in key panels and discussions

IGTP experts shared their knowledge in crucial sessions at the congress:

• Tuesday, 4 March - Dr Victoria Delgado, Head of the Cardiovascular Imaging Section at Hospital Universitari Germans Trias i Pujol and Scientific Director at the Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), moderated the panel Big data and deep learning: the new diagnostic DNA as part of the Innovation for a Healthier Future: Transforming Care Today session at 4YFN. The discussion focused on the role of artificial intelligence in medical diagnostics and its applications in precision medicine.
• Wednesday, 5 March - Dr Rafael de Cid, leader of IGTP's GCAT - Genomes for Life project, participated in the roundtable DATOS-CAT: From Clinical Data to Interoperable and Usable Knowledge, where experts discussed the challenges and opportunities of integrating clinical, genomic, and epidemiological data into research and healthcare innovation.

IGTP spin-offs at 4YFN

IGTP was also present at the 4YFN entrepreneurship space, where three of its spin-offs presented their innovative solutions in digital health and medical technologies:

• Time is Brain - presented its tools for optimising stroke management and improving patient outcomes.
• NIMBLE Diagnostics - showcased its technology for remote monitoring of vascular prostheses using electromagnetic wave ultrasound.
• Swan Medical - introduced its innovative solutions for improving minimally invasive surgical techniques.
• HealthTech Innovations – presented its AI and VR solutions for the healthcare sector.

Showcasing TB-OMICS: AI for early tuberculosis detection

Another highlight was the presentation of TB-OMICS, led by Dr José Domínguez at IGTP, which aims to develop a deep learning-based software for early tuberculosis (TB) detection by analysing metabolomic data obtained through low-field nuclear magnetic resonance (NMR). This innovative approach could represent a paradigm shift in TB diagnosis, enabling faster and more accurate patient identification.

Exploring new collaborations in biomedical innovation

Beyond the sessions and presentations, Dr Victoria Delgado (Scientific Director, CMCiB) and Dr Míriam Gironès (Director of Business Development, CMCiB) used their participation at MWC25 to explore new collaboration opportunities with key players in the technology and biomedical industries, particularly in the fields of digital health, AI in medicine, and medical technology innovation.

With its presence at MWC Barcelona 2025, IGTP reinforced its role as a leading centre for biomedical innovation and health technology, contributing to the development of disruptive solutions in translational research and precision medicine.